FDA Import Refusal AEK-8613440-7/21/1 — Merck, Inc.

Merck, Inc. — FEI 2210048

The FDA refused shipment AEK-8613440-7/21/1 from Merck, Inc. (United States) on Jan 19, 2021. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.